Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.045 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.049 | 0.7 |